Published in Brain Res on January 28, 2010
Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell (2010) 3.28
Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatry (2012) 1.45
Neurobiology of rodent self-grooming and its value for translational neuroscience. Nat Rev Neurosci (2015) 1.12
Double deletion of melanocortin 4 receptors and SAPAP3 corrects compulsive behavior and obesity in mice. Proc Natl Acad Sci U S A (2013) 0.89
Influence of lead on repetitive behavior and dopamine metabolism in a mouse model of iron overload. Toxicol Res (2014) 0.87
Neuroligin 1 modulates striatal glutamatergic neurotransmission in a pathway and NMDAR subunit-specific manner. Front Synaptic Neurosci (2015) 0.82
Mouse models of neurodevelopmental disease of the basal ganglia and associated circuits. Curr Top Dev Biol (2014) 0.81
Rare missense neuronal cadherin gene (CDH2) variants in specific obsessive-compulsive disorder and Tourette disorder phenotypes. Eur J Hum Genet (2013) 0.81
Murine motor and behavior functional evaluations for acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication. J Neuroimmune Pharmacol (2011) 0.79
Influence of mesenchymal stem cell transplantation on stereotypic behavior and dopamine levels in rats with Tourette syndrome. PLoS One (2013) 0.78
OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior. Proc Natl Acad Sci U S A (2017) 0.77
The effects of methylphenidate on cognitive performance of healthy male rats. Front Neurosci (2013) 0.76
Animal Models of Tourette Syndrome-From Proliferation to Standardization. Front Neurosci (2016) 0.76
Addressing the Complexity of Tourette's Syndrome through the Use of Animal Models. Front Neurosci (2016) 0.75
Effect of mesenchymal stem cell transplantation on brain-derived neurotrophic factor expression in rats with Tourette syndrome. Exp Ther Med (2016) 0.75
Unilateral Lesion of Dopamine Neurons Induces Grooming Asymmetry in the Mouse. PLoS One (2015) 0.75
Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation. J Huntingtons Dis (2016) 0.75
Tourette syndrome research highlights from 2016. F1000Res (2017) 0.75
The functional anatomy of basal ganglia disorders. Trends Neurosci (1989) 12.28
Disturbance of sequential movements in patients with Parkinson's disease. Brain (1987) 2.30
Recent advances in Tourette syndrome research. Trends Neurosci (2006) 2.13
Animal models of neurological deficits: how relevant is the rat? Nat Rev Neurosci (2002) 1.96
Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology (1998) 1.70
Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann Neurol (2005) 1.65
Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis. Pediatr Neurol (2001) 1.61
Coding of serial order by neostriatal neurons: a "natural action" approach to movement sequence. J Neurosci (1998) 1.60
SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther (1983) 1.49
Sequential arm movements in patients with Parkinson's disease, Huntington's disease and dystonia. Brain (1992) 1.48
Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's. BMC Biol (2005) 1.30
Neurobiology of basal ganglia and Tourette syndrome: basal ganglia circuits and thalamocortical outputs. Adv Neurol (2006) 1.29
Persistent increase in olfactory type G-protein alpha subunit levels may underlie D1 receptor functional hypersensitivity in Parkinson disease. J Neurosci (2004) 1.23
Elevated intrasynaptic dopamine release in Tourette's syndrome measured by PET. Am J Psychiatry (2002) 1.22
Implementation of action sequences by a neostriatal site: a lesion mapping study of grooming syntax. J Neurosci (1996) 1.22
Analyzing grooming microstructure in neurobehavioral experiments. Nat Protoc (2007) 1.18
Cortex, striatum and cerebellum: control of serial order in a grooming sequence. Exp Brain Res (1992) 1.14
Sequencing in Parkinson's disease. Abnormalities in programming and controlling movement. Brain (1991) 1.12
Grooming behavior in the rat. J Comp Physiol Psychol (1960) 1.11
Natural syntax rules control action sequence of rats. Behav Brain Res (1987) 1.07
Progressive degradation of serial grooming chains by descending decerebration. Behav Brain Res (1989) 1.03
The neonate-6-hydroxydopamine-lesioned rat: a model for clinical neuroscience and neurobiological principles. Brain Res Brain Res Rev (2005) 0.99
The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum. Neuroscience (1990) 0.97
Neurobiology of basal ganglia and Tourette syndrome: striatal and dopamine function. Adv Neurol (2006) 0.97
OCD-Like behaviors caused by a neuropotentiating transgene targeted to cortical and limbic D1+ neurons. J Neurosci (1999) 0.95
Induction by dopamine D1 receptor agonist ABT-431 of dyskinesia similar to levodopa in patients with Parkinson disease. Arch Neurol (2001) 0.95
Dopamine D1 and D2 receptor contributions to L-DOPA-induced dyskinesia in the dopamine-depleted rat. Pharmacol Biochem Behav (2005) 0.93
Substantia nigra pars reticulata neurons code initiation of a serial pattern: implications for natural action sequences and sequential disorders. Eur J Neurosci (2002) 0.92
Selective localization of striatal D1 receptors to striatonigral neurons. Brain Res (1990) 0.91
Action sequencing is impaired in D1A-deficient mutant mice. Eur J Neurosci (1998) 0.90
Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation. J Pharmacol Exp Ther (1986) 0.89
Pathophysiology of tics and Tourette syndrome. J Neurol (2003) 0.88
Stereotypic behaviour in the deer mouse: pharmacological validation and relevance for obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry (2007) 0.87
Neuroimaging of Tourette syndrome. J Child Neurol (2006) 0.87
Neurophysiology of Tourette's syndrome: pathophysiological considerations. Brain Dev (2003) 0.86
Dopamine antagonists in tic-related and psychotic spectrum obsessive compulsive disorder. J Clin Psychiatry (1994) 0.86
Gilles de la Tourette syndrome: symptomatic treatment based on evidence. Eur Child Adolesc Psychiatry (2000) 0.86
Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists. Synapse (2000) 0.85
Super-stereotypy I: enhancement of a complex movement sequence by systemic dopamine D1 agonists. Synapse (2000) 0.85
Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats. Life Sci (1986) 0.85
Obsessive-compulsive disorder in Tourette syndrome. J Child Neurol (2006) 0.84
Pharmacological options for the treatment of Tourette's disorder. Drugs (2001) 0.84
Dopamine transporter density of basal ganglia assessed with [123I]IPT SPET in obsessive-compulsive disorder. Eur J Nucl Med Mol Imaging (2003) 0.84
Preclinical models relevant to Tourette syndrome. Adv Neurol (2006) 0.83
Dopamine receptors in the basal ganglia: relevance to Parkinson's disease. Mov Disord (1993) 0.83
Behavioural pharmacology of 'D-1-like' dopamine receptors: further subtyping, new pharmacological probes and interactions with 'D-2-like' receptors. Prog Neuropsychopharmacol Biol Psychiatry (1995) 0.83
D1 receptor blockade improves L-dopa-induced dyskinesia but worsens parkinsonism in MPTP monkeys. Neurology (1999) 0.83
Selective D-1 dopamine receptor increase following chronic treatment with SCH 23390. Eur J Pharmacol (1985) 0.82
Parametric and pharmacological analyses of the enhanced grooming response elicited by the D1 dopamine receptor agonist SKF 38393 in the rat. Psychopharmacology (Berl) (1992) 0.82
Washing, drying, and anointing in adult humans (Homo sapiens): commonalities with grooming sequences in rodents. J Comp Psychol (1991) 0.80
Pharmacological characterization in the rat of grooming and other behavioural responses to the D1 dopamine receptor agonist R-SK&F 38393. J Psychopharmacol (1987) 0.78
Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming. Psychopharmacology (Berl) (1990) 0.78
Locomotor behaviors in response to new selective D-1 and D-2 dopamine receptor agonists, and the influence of selective antagonists. Pharmacol Biochem Behav (1986) 0.78
The evolution of the butyrophenones, haloperidol and trifluperidol, from meperidine-like 4-phenylpiperidines. Int Rev Neurobiol (1965) 0.77
Dopamine D-1 and D-2 receptor agonists and antagonists and neuropeptide-induced excessive grooming. Eur J Pharmacol (1989) 0.77
Up-regulated dopamine D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxydopamine, treatments. Eur J Pharmacol (2003) 0.76
Addiction. Annu Rev Psychol (2002) 6.70
Review. The incentive sensitization theory of addiction: some current issues. Philos Trans R Soc Lond B Biol Sci (2008) 5.54
The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci (2002) 4.70
Dissecting components of reward: 'liking', 'wanting', and learning. Curr Opin Pharmacol (2009) 4.46
Hedonic hot spot in nucleus accumbens shell: where do mu-opioids cause increased hedonic impact of sweetness? J Neurosci (2005) 3.10
Ventral pallidum firing codes hedonic reward: when a bad taste turns good. J Neurophysiol (2006) 2.62
Unconscious affective reactions to masked happy versus angry faces influence consumption behavior and judgments of value. Pers Soc Psychol Bull (2005) 2.42
Positive and negative motivation in nucleus accumbens shell: bivalent rostrocaudal gradients for GABA-elicited eating, taste "liking"/"disliking" reactions, place preference/avoidance, and fear. J Neurosci (2002) 2.30
Opioid limbic circuit for reward: interaction between hedonic hotspots of nucleus accumbens and ventral pallidum. J Neurosci (2007) 2.18
Ventral pallidum roles in reward and motivation. Behav Brain Res (2008) 2.12
The ventral pallidum and hedonic reward: neurochemical maps of sucrose "liking" and food intake. J Neurosci (2005) 2.10
Endocannabinoid hedonic hotspot for sensory pleasure: anandamide in nucleus accumbens shell enhances 'liking' of a sweet reward. Neuropsychopharmacology (2007) 2.09
Disentangling pleasure from incentive salience and learning signals in brain reward circuitry. Proc Natl Acad Sci U S A (2011) 2.09
Persistent neurochemical and behavioral abnormalities in adulthood despite early iron supplementation for perinatal iron deficiency anemia in rats. Behav Brain Res (2006) 2.02
Hyperdopaminergic mutant mice have higher "wanting" but not "liking" for sweet rewards. J Neurosci (2003) 2.00
Towards a functional neuroanatomy of pleasure and happiness. Trends Cogn Sci (2009) 1.98
Hedonic hot spots in the brain. Neuroscientist (2006) 1.96
Instant transformation of learned repulsion into motivational "wanting". Curr Biol (2013) 1.96
Neural correlates of social and nonsocial emotions: An fMRI study. Neuroimage (2006) 1.82
Which cue to "want?" Central amygdala opioid activation enhances and focuses incentive salience on a prepotent reward cue. J Neurosci (2009) 1.81
Emotional environments retune the valence of appetitive versus fearful functions in nucleus accumbens. Nat Neurosci (2008) 1.80
Mesolimbic dopamine in desire and dread: enabling motivation to be generated by localized glutamate disruptions in nucleus accumbens. J Neurosci (2008) 1.76
Enkephalin surges in dorsal neostriatum as a signal to eat. Curr Biol (2012) 1.74
Ventral pallidal neurons code incentive motivation: amplification by mesolimbic sensitization and amphetamine. Eur J Neurosci (2005) 1.64
Glutamate motivational ensembles in nucleus accumbens: rostrocaudal shell gradients of fear and feeding. Eur J Neurosci (2003) 1.62
Dynamic computation of incentive salience: "wanting" what was never "liked". J Neurosci (2009) 1.55
Nucleus accumbens corticotropin-releasing factor increases cue-triggered motivation for sucrose reward: paradoxical positive incentive effects in stress? BMC Biol (2006) 1.49
Identification of the subthalamic nucleus in deep brain stimulation surgery with a novel wavelet-derived measure of neural background activity. J Neurosurg (2009) 1.49
A neural computational model of incentive salience. PLoS Comput Biol (2009) 1.48
Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's. BMC Biol (2005) 1.30
Model-based and model-free Pavlovian reward learning: revaluation, revision, and revelation. Cogn Affect Behav Neurosci (2014) 1.22
Ventral pallidal representation of pavlovian cues and reward: population and rate codes. J Neurosci (2004) 1.21
Dopamine or opioid stimulation of nucleus accumbens similarly amplify cue-triggered 'wanting' for reward: entire core and medial shell mapped as substrates for PIT enhancement. Eur J Neurosci (2013) 1.19
Analyzing grooming microstructure in neurobehavioral experiments. Nat Protoc (2007) 1.18
Desire and dread from the nucleus accumbens: cortical glutamate and subcortical GABA differentially generate motivation and hedonic impact in the rat. PLoS One (2010) 1.12
Reward uncertainty enhances incentive salience attribution as sign-tracking. Behav Brain Res (2012) 1.10
Nucleus accumbens dopamine/glutamate interaction switches modes to generate desire versus dread: D(1) alone for appetitive eating but D(1) and D(2) together for fear. J Neurosci (2011) 1.10
Which cue to 'want'? Opioid stimulation of central amygdala makes goal-trackers show stronger goal-tracking, just as sign-trackers show stronger sign-tracking. Behav Brain Res (2012) 1.09
What and when to "want"? Amygdala-based focusing of incentive salience upon sugar and sex. Psychopharmacology (Berl) (2011) 1.08
Mapping brain circuits of reward and motivation: in the footsteps of Ann Kelley. Neurosci Biobehav Rev (2012) 1.07
Basal ganglia neural mechanisms of natural movement sequences. Can J Physiol Pharmacol (2004) 1.04
Opioid hedonic hotspot in nucleus accumbens shell: mu, delta, and kappa maps for enhancement of sweetness "liking" and "wanting". J Neurosci (2014) 1.01
Prefrontal cortex modulates desire and dread generated by nucleus accumbens glutamate disruption. Biol Psychiatry (2012) 0.98
DECISION UTILITY, THE BRAIN, AND PURSUIT OF HEDONIC GOALS. Soc Cogn (2008) 0.98
An orexin hotspot in ventral pallidum amplifies hedonic 'liking' for sweetness. Neuropsychopharmacology (2013) 0.98
Discrete forebrain neuronal networks supporting noradrenergic regulation of sensorimotor gating. Neuropsychopharmacology (2011) 0.93
Substantia nigra pars reticulata neurons code initiation of a serial pattern: implications for natural action sequences and sequential disorders. Eur J Neurosci (2002) 0.92
The functional neuroanatomy of pleasure and happiness. Discov Med (2010) 0.92
Altered locus coeruleus-norepinephrine function following single prolonged stress. Eur J Neurosci (2012) 0.92
Endogenous opioids are necessary for benzodiazepine palatability enhancement: naltrexone blocks diazepam-induced increase of sucrose-'liking'. Pharmacol Biochem Behav (2005) 0.88
Excessive disgust caused by brain lesions or temporary inactivations: mapping hotspots of the nucleus accumbens and ventral pallidum. Eur J Neurosci (2014) 0.87
Improved signal and reduced noise in neural recordings from close-spaced electrode arrays using independent component analysis as a preprocessor. J Neurosci Methods (2006) 0.85
Metabotropic glutamate receptor blockade in nucleus accumbens shell shifts affective valence towards fear and disgust. Eur J Neurosci (2010) 0.83
Dopamine D1 activation shortens the duration of phases in stereotyped grooming sequences. Behav Processes (2005) 0.82
Differential subjective and psychophysiological responses to socially and nonsocially generated emotional stimuli. Emotion (2006) 0.82
Nucleus accumbens GABAergic inhibition generates intense eating and fear that resists environmental retuning and needs no local dopamine. Eur J Neurosci (2013) 0.81
Mutual independence of 5-HT(2) and α1 noradrenergic receptors in mediating deficits in sensorimotor gating. Psychopharmacology (Berl) (2011) 0.80
The anatomical and electrophysiological subthalamic nucleus visualized by 3-T magnetic resonance imaging. Neurosurgery (2012) 0.80
The Neuroscience of Happiness and Pleasure. Soc Res (New York) (2010) 0.79
The joyful mind. Sci Am (2012) 0.78
Decision Utility, Incentive Salience, and Cue-Triggered "Wanting" Oxf Ser Soc Cogn Soc Neurosci (2009) 0.76